Doctors Debunk Intermittent Fasting Hype

- The medical review in question was a comprehensive analysis by Cochrane, which synthesized the results of 22 different clinical trials involving a total of 1,995 adults. - Researchers in the review examined multiple forms of intermittent fasting, including alternate-day fasting, the 5:2 diet (fasting two days a week), and time-restricted eating, with most studies tracking participants for up to one year. - When compared directly with traditional continuous calorie restriction, multiple analyses have concluded that intermittent fasting is generally not superior for weight loss, with both methods achieving similar results. - The primary mechanism for weight loss in most intermittent fasting studies is simply a reduction in overall calorie intake, as a shorter eating window often leads to people eating less. - While the broad Cochrane review found little benefit, some individual studies have shown intermittent fasting to be more effective; a 2025 study, for example, found a 4:3 fasting schedule resulted in 7.6% body weight loss compared to 5% for daily calorie restriction. - A significant limitation of existing research is the lack of long-term data, as most clinical trials have followed participants for 12 months or less, making it difficult to assess the sustainability and long-term health impacts. - Reported side effects of intermittent fasting can include fatigue, headaches, irritability, and nausea, and its safety has not been established for individuals with a history of eating disorders or for those who are pregnant or breastfeeding. - In contrast to the ambiguity of fasting data, the benefits of the recommended alternatives are well-documented; regular exercise, for instance, is proven to combat conditions like heart disease and high blood pressure by boosting "good" HDL cholesterol.